Vanguards of Healthcare: Field Medical to Expand PFA’s Reach
“We don’t have any purpose-built technologies for the treatment of VT (ventricular tachycardia), and when I had a chance to look at what Field was building and the opportunity here...
By Aditya Somani · Bloomberg
“We don’t have any purpose-built technologies for the treatment of VT (ventricular tachycardia), and when I had a chance to look at what Field was building and the opportunity here to build out a new space and a new sector, it was very exciting to me,” Field Medical CEO Mark Turco explains regarding new areas for pulsed field ablation (PFA) innovation. In this episode of the Vanguards of Healthcare podcast, Turco and Field Medical Founder Steven Mickelsen sit down with Bloomberg Intelligence ana